What is the recommended dose and frequency of clonidine (antihypertensive medication) for the treatment of anxiety?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 17, 2025 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

From the Guidelines

Clonidine for anxiety is typically prescribed at a starting dose of 0.1 mg taken 2 times daily, with a total daily dose ranging from 0.1 to 0.8 mg, as indicated in the 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults 1, 2, 3, 1, 4. The medication should be started at the lowest effective dose and gradually increased if needed, under medical supervision. Clonidine works by stimulating alpha-2 adrenergic receptors in the brain, which reduces sympathetic outflow and decreases physical symptoms of anxiety such as rapid heart rate, high blood pressure, and feelings of agitation. Some key points to consider when prescribing clonidine for anxiety include:

  • Starting with a low dose and gradually increasing as needed
  • Taking the medication consistently at the same times each day
  • Avoiding abrupt cessation, which can cause rebound hypertension and anxiety
  • Monitoring for side effects, such as drowsiness, dry mouth, dizziness, and constipation, particularly when starting treatment
  • Regular follow-up with a healthcare provider to monitor effectiveness and adjust dosing as needed It's also important to note that while clonidine is FDA-approved for hypertension and ADHD, its use for anxiety is considered off-label, but it's particularly helpful for anxiety with prominent physical symptoms or when other anxiety medications have failed or are contraindicated, as mentioned in a study on the use of clonidine in ADHD treatment 5.

From the FDA Drug Label

DOSAGE AND ADMINISTRATION Adults The dose of clonidine hydrochloride tablets, USP must be adjusted according to the patient’s individual blood pressure response. Initial Dose 0.1 mg tablet twice daily (morning and bedtime). Maintenance Dose Further increments of 0. 1 mg per day may be made at weekly intervals if necessary until the desired response is achieved. The therapeutic doses most commonly employed have ranged from 0.2 mg to 0.6 mg per day given in divided doses.

The FDA drug label does not answer the question.

From the Research

Clonidine Dose and Frequency for Anxiety

  • The dose of clonidine for anxiety can vary, but one study suggests a range of 0.15 to 0.7 mg/day 6.
  • This study observed the effects of adjunctive clonidine on symptoms experienced during and after gradual alprazolam discontinuation in panic disorder patients.
  • Another study discusses the use of alpha- and beta-adrenergic medications, such as clonidine, for the treatment of anxiety disorders, but does not specify a particular dose or frequency 7.
  • Clonidine is also mentioned as a potential treatment for anxiety disorders in other studies, but the dose and frequency are not specified 8, 9.
  • A study on the use of clonidine for sedation and analgesia in critically ill adults found that high-dose clonidine (>0.4 mg/day) was associated with a decrease in opioid requirements, but the dose and frequency for anxiety specifically are not discussed 10.

Potential Dose Ranges

  • 0.15 to 0.7 mg/day 6
  • 0.4 mg/day (high-dose) 10

  • ≤0.4 mg/day (low-dose) 10

Frequency

  • The frequency of clonidine administration for anxiety is not explicitly stated in the provided studies, but it is mentioned that clonidine was administered for 1 week in one study 6.

References

Guideline

practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults.

Journal of the American Academy of Child and Adolescent Psychiatry, 2002

Research

Anxiety disorders: a comprehensive review of pharmacotherapies.

The Mount Sinai journal of medicine, New York, 2008

Related Questions

What should I prescribe for a patient with severe anxiety who has tried every Selective Serotonin Reuptake Inhibitor (SSRI) and Serotonin-Norepinephrine Reuptake Inhibitor (SNRI)?
How do medications such as selective serotonin reuptake inhibitors (SSRIs), serotonin‑norepinephrine reuptake inhibitors (SNRIs), benzodiazepines, buspirone, pregabalin, and propranolol reduce anxiety?
What alternative pharmacologic treatments are available for episodic anxiety and panic attacks besides benzodiazepines and hydroxyzine?
What is the appropriate management for a 28-year-old patient with anxiety and panic attacks who is taking sertraline 100 mg daily, buspirone 10 mg three times daily, and propranolol 10 mg three times daily, and is now experiencing a severe anxiety/panic attack?
What medication management, including dose and frequency adjustments, is appropriate for a 65‑year‑old patient on citalopram 40 mg daily, atomoxetine (Strattera) 80 mg daily, buspirone 5 mg twice daily, and hydroxyzine 10 mg twice daily as needed, who continues to have significant anxiety?
What is the effect of restricted fluid intake on blood glucose levels?
What form of Dehydroepiandrosterone (DHEA) supplementation is most effective in men?
Is sertraline (Zoloft) associated with dark urine, a potential indicator of impaired renal function or hepatic dysfunction?
Is Buscopan (Hyoscine) used for the treatment of cholelithiasis?
What is the relationship between semaglutide (GLP-1 receptor agonist) and dark urine, a potential indicator of impaired renal function or hepatic dysfunction?
How does water intoxication, also known as Hyponatremia (low sodium levels in the blood), cause seizures?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.